Foscarnet Kabi

Foscarnet Sodium Hexahydrate is an antiviral medication used intravenously for managing certain viral infections. It is manufactured by Fresenius Kabi Deutschland Gmbh and is available in the EU market.

Foscarnet Sodium Hexahydrate is primarily used for the treatment of viral infections, particularly those caused by herpesviruses. It is often prescribed for conditions where other antiviral treatments may not be effective. The medication works by inhibiting the replication of the virus, helping to control the infection.

Common effects of Foscarnet Sodium Hexahydrate may include nausea, vomiting, and changes in kidney function. Some individuals might experience dizziness or headaches. It is important to monitor for any signs of adverse reactions and consult a healthcare provider if severe side effects occur.

Foscarnet Sodium Hexahydrate should be handled with care, especially in individuals with pre-existing kidney conditions. Regular monitoring of kidney function is recommended during treatment. It is crucial to follow the prescribed dosage and administration guidelines to minimize potential risks.

Foscarnet Sodium Hexahydrate may interact with other medications, particularly those that affect kidney function. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain over-the-counter drugs may also impact the effectiveness of Foscarnet Sodium Hexahydrate.